MedPath

KBC SPLIT

πŸ‡­πŸ‡·Croatia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
2 (100.0%)

Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children

Recruiting
Conditions
Acute Appendicitis
Acute Appendicitis With Rupture
Abdominal Pain (AP)
First Posted Date
2025-06-06
Last Posted Date
2025-06-06
Lead Sponsor
KBC Split
Target Recruit Count
100
Registration Number
NCT07008092
Locations
πŸ‡­πŸ‡·

University Hospital of Split, Split, Croatia

Diagnostic Importance of the Circulating Human Leucine-rich Ξ±-2-glycoprotein in Acute Appendicitis in Pediatric Patients

Conditions
Appendicitis Acute
First Posted Date
2021-10-26
Last Posted Date
2022-04-07
Lead Sponsor
KBC Split
Target Recruit Count
90
Registration Number
NCT05093660
Locations
πŸ‡­πŸ‡·

University Hospital Split, Split, Splitsko-dalmatinska, Croatia

The Effect of Subcutaneous and Intraperitoneal Anesthesia on Post Laparoscopic Pain

Not Applicable
Completed
Conditions
Varicocele
Postoperative Pain
Interventions
First Posted Date
2021-09-05
Last Posted Date
2021-09-05
Lead Sponsor
KBC Split
Target Recruit Count
60
Registration Number
NCT05034406
Locations
πŸ‡­πŸ‡·

University Hospital Split, Split, Splitsko-dalmatinska, Croatia

Unilateral Laparoscopic Diathermy Adjusted to Ovarian Volume

Not Applicable
Completed
Conditions
PCOS
First Posted Date
2013-04-17
Last Posted Date
2013-04-17
Lead Sponsor
KBC Split
Target Recruit Count
96
Registration Number
NCT01833949
Locations
πŸ‡­πŸ‡·

Clinical Hospital Center Split, Split, Dalmatia, Croatia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.